Dr. Mounia Azzi, Vice President, Program Development & Partnership
Dr. Joseph Mancini, Vice President, Innovation Biology
Dr. Claudio Sturino, Senior Director & Head of Chemistry and Pharmaceutical Development
This seminar, presented by Dr. Amie Phinney, will review critical scientific and investment-readiness considerations for academics aiming to translate therapeutic academic discoveries into impactful medicinal products.
In addition, Dr. Phinney will present an overview of data package considerations, industry trends and venture-backed partnering models. Dr. Phinney's talk will be followed by a panel discussion and audience Q&A with adMare’s R&D and commercial leadership team to address both the scientific and commercialization questions from U of T’s bio-entrepreneur community.
About adMare BioInnovations:
With a wealth of scientific discovery, Canada is primed to be a global leader in life sciences. To realize this potential, adMare uses its scientific and commercial expertise, specialized R&D infrastructure, and investment capital to build investable companies, robust ecosystems and industry-ready talent – and re-invests its returns back into the Canadian industry to ensure it is sustained for the long-term.